tiprankstipranks
Kymera Therapeutics, Inc. (KYMR)
NASDAQ:KYMR
US Market

Compare Kymera Therapeutics (KYMR) vs. Competitors

423 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Kymera Therapeutics
$85.05
$6.94B
279.69%
17 Buy
0 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$98.82
$6.31B
-42.66
141.67%
10 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$40.79
$5.21B
141.40
117.08%
3 Buy
16 Hold
0 Sell
Hold
Crinetics Pharmaceuticals
$39.44
$4.13B
-8.91
46.89%
8 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$17.96
$1.29B
-3.74
-47.13%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KYMR
Kymera Therapeutics
85.05
59.62
234.45%
PTGX
Protagonist Therapeutics
98.82
53.79
119.45%
APLS
Apellis Pharmaceuticals
40.79
21.46
111.02%
CRNX
Crinetics Pharmaceuticals
39.44
9.66
32.44%
AKRO
MLTX
MoonLake Immunotherapeutics
17.96
-17.79
-49.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts